Works matching DE "IMMUNE checkpoint inhibitors"

Results: 5000
    1
    2

    Immunotherapy-related pneumonitis.

    Published in:
    Eurasian Journal of Pulmonology, 2025, v. 27, n. 1, p. 1, doi. 10.14744/ejp.2024.5005
    By:
    • Türk, Merve Ayık;
    • Unat, Damla Serçe;
    • Kanat, Nazan Erbaş;
    • Kabalak, Pınar Akın
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study.

    Published in:
    Journal of Gastroenterology, 2025, v. 60, n. 6, p. 738, doi. 10.1007/s00535-025-02233-z
    By:
    • Aoki, Tomoko;
    • Kudo, Masatoshi;
    • Nishida, Naoshi;
    • Ueshima, Kazuomi;
    • Tsuchiya, Kaoru;
    • Tada, Toshifumi;
    • Morita, Masahiro;
    • Chishina, Hirokazu;
    • Takita, Masahiro;
    • Hagiwara, Satoru;
    • Ida, Hiroshi;
    • Minami, Yasunori;
    • Kuroda, Hidekatsu;
    • Nakamura, Noriaki;
    • Hiraoka, Atsushi;
    • Tomonari, Tetsu;
    • Tani, Joji;
    • Naganuma, Atsushi;
    • Kakizaki, Satoru;
    • Ogawa, Chikara
    Publication type:
    Article
    28
    29
    30
    31

    Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1557652
    By:
    • Caterino, Marianna;
    • Lo Giudice, Giorgio;
    • Damiano, Vincenzo;
    • Perri, Francesco;
    • Giordano, Guido;
    • Ciardiello, Davide;
    • Mirabile, Aurora;
    • Pirozzi, Mario;
    • Sponghini, Andrea Pietro;
    • Ricci, Vincenzo;
    • Montella, Liliana;
    • Addeo, Raffaele;
    • Vignani, Francesca;
    • Famiglietti, Vincenzo;
    • Farese, Stefano;
    • Di Lorenzo, Sara;
    • Ciardiello, Fortunato;
    • Fasano, Morena
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39

    Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1585597
    By:
    • González Muñoz, Cynthia;
    • Álvarez Arzola, Rydell;
    • Calvo Pérez, Adanays;
    • Frometa Campanón, Milagro de la Caridad;
    • Hernández Casaña, Patricia;
    • Fernández-Calienes Valdés, Aymé;
    • Lorenzo-Luaces, Patricia;
    • Mazorra Herrera, Zaima;
    • Crombet Ramos, Tania;
    • Labrada Mon, Mayrel
    Publication type:
    Article
    40
    41
    42
    43

    Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-59840-w
    By:
    • Chao, Chih-Jia;
    • Zhang, Endong;
    • Trinh, Duong N.;
    • Udofa, Edidiong;
    • Lin, Hanchen;
    • Silvers, Caylee;
    • Huo, Jiawei;
    • He, Shan;
    • Zheng, Jingtian;
    • Cai, Xiaoying;
    • Bao, Qing;
    • Zhang, Luyu;
    • Phan, Philana;
    • Elgendy, Sara M.;
    • Shi, Xiangqian;
    • Burdette, Joanna E.;
    • Lee, Steve Seung-Young;
    • Gao, Yu;
    • Zhang, Peng;
    • Zhao, Zongmin
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    局部晚期宫颈癌免疫治疗进展.

    Published in:
    Practical Oncology Journal, 2025, v. 39, n. 2, p. 157, doi. 10.11904/j.issn.1002-3070.2025.02.012
    By:
    • 王孟菲;
    • 综述;
    • 许波群;
    • 审校
    Publication type:
    Article